295 related articles for article (PubMed ID: 12749748)
1. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
Gawrieh S; Shaker R
Drugs Aging; 2003; 20(7):509-16. PubMed ID: 12749748
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
3. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
5. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
6. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
[TBL] [Abstract][Full Text] [Related]
7. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus.
Wurm P; de Caestecker J
Expert Opin Pharmacother; 2003 Jul; 4(7):1049-61. PubMed ID: 12831333
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
11. Gastro-oesophageal reflux disease.
Moayyedi P; Talley NJ
Lancet; 2006 Jun; 367(9528):2086-100. PubMed ID: 16798392
[TBL] [Abstract][Full Text] [Related]
12. Acid reflux and gastro-oesophageal reflux disease.
Watson AR; Bowling TE
Br J Community Nurs; 2004 Aug; 9(8):326-30. PubMed ID: 15365470
[TBL] [Abstract][Full Text] [Related]
13. Medical treatment of gastro-oesophageal reflux disease.
De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
[TBL] [Abstract][Full Text] [Related]
14. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
[TBL] [Abstract][Full Text] [Related]
16. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
Galmiche JP
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S3-6. PubMed ID: 10929891
[TBL] [Abstract][Full Text] [Related]
17. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
Lambert R
Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
[TBL] [Abstract][Full Text] [Related]
18. Gastro-oesophageal reflux disease.
de Carle DJ
Med J Aust; 1998 Nov; 169(10):549-54. PubMed ID: 9861914
[TBL] [Abstract][Full Text] [Related]
19. Trends in the management of gastro-oesophageal reflux disease.
Lee JM; O'Morain CA
Postgrad Med J; 1998 Mar; 74(869):145-50. PubMed ID: 9640439
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
